Phase 1
N=4
Improving Rehabilitation by Magnetic Brain Stimulation
Stroke
Bottom Line
View on ClinicalTrials.gov: NCT00636701 ↗Enrolled (actual)
4
Serious AEs
0.0%
Results posted
May 2015
Primary outcome: Primary: Percentage BOLD (Blood-oxygen-level Dependent Contrast Imaging) Signal From Baseline at 2 Weeks — 3; 2 percentage change of BOLD
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 1
- Interventions
- Repetitive Transcranial Magnetic Stimulation (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Mar 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage BOLD (Blood-oxygen-level Dependent Contrast Imaging) Signal From Baseline at 2 Weeks |
3; 2 | — |
Summary
We hope to understand the properties of the motor cortex in the brain of people with stroke using non-invasive magnetic stimulation.
Eligibility Criteria
Inclusion Criteria
- 3-24 months post stroke
- upper limb paresis
- CES-D below 16,
Exclusion Criteria
- history of seizure
- metal in head
- score of less than 24 on the Folstein Mini-Mental Status Exam
- clinical judgement of excessive frailty or lack of stamina (e.g. cannot attend to instructions, stay awake, engage in functional activities)
- serious uncontrolled medical condition
- excessive pain in any joint of the more affected extremity that could limit ability to cooperate with the intervention as judged by the examining clinician
Data sourced from ClinicalTrials.gov (NCT00636701). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.